Saniona AB (CHIX:SANIOS) Quality Rank


CHIX:SANIOS Saniona AB CHIX:SANIOS
65 GF Score
Price kr12.75
GF Value kr26.65
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Saniona AB Quality Rank Related Terms

CHIX:SANIOS
65GF Score
Saniona AB CHIX:SANIOS
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Saniona AB (CHIX:SANIOS) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of kr12.75 is trading 52.2% below its estimated GF Value™ of kr26.65. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for CHIX:SANIOS:

  • Quality Rank:
  • GF Value™: kr26.65 vs. price of kr12.75 (52.2% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the CHIX:SANIOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
65GF Score

Get the complete analysis for CHIX:SANIOS

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.75
Price
kr26.65
GF Value